Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 901–1,000 of 1,001
Risk-assessment and Coping Strategies Segregate with Divergent Intrinsic Aerobic Capacity in Rats
Burghardt, P. R., Flagel, S. B., Burghardt, K. J., Britton, S. L., Koch, L. G., Watson, S. J., & Akil, H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.144 · Cited by 27
“…hormone (CRH) is a neuropeptide mediating HPA-activation in response to stress (Bale and Vale, 2004), anxiety (Britton et al , 1985), and depression (Nemeroff et al , 1984), as well as the regulation food intake (Britton et al , 1982; Mastorakos and Zapanti, 2004; Richardson et al , 2002).”
Identifying Early Behavioral and Molecular Markers of Future Stress Sensitivity
Goel, N., & Bale, T. L. (2007) · Endocrinology · doi:10.1210/en.2007-0479 · Cited by 25
Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications
Marano, G., Harnic, D., Lotrionte, M., Biondi‐Zoccai, G., Abbate, A., Romagnoli, E., & Mazza, M. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.78 · Cited by 25
Individual Differences and the Stress Response: Studies of a Wild Primate
Sapolsky, R. M. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2064-5_31 · Cited by 23
Depression and immune function
Irwin, M. R. (1988) · Stress Medicine · doi:10.1002/smi.2460040206 · Cited by 24
Laue, L., Gold, P. W., Richmond, A., & Chrousos, G. P. (1991) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00268-8 · Cited by 26
Antiglucocorticoids as Treatments for Depression: Rationale for Use and Therapeutic Potential
Price, L. H., Malison, R. T., McDougle, C. J., & Pelton, G. H. (1996) · CNS Drugs · doi:10.2165/00023210-199605050-00001 · Cited by 24
Characterization of corticotropin-releasing factor receptors in dissociated brain cell cultures
Kapcala, L. P., & Souza, E. B. D. (1988) · Brain Research · doi:10.1016/0006-8993(88)90357-5 · Cited by 24
Association of Depression with Subclinical Coronary Atherosclerosis: a Systematic Review
Khan, S. A., Shahzad, U., Zarak, M. S., Channa, J., Khan, I., & Ghani, M. O. A. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-09985-4 · Cited by 23
Mechanisms of Psychiatric Comorbidities in Epilepsy
Maguire, J. L. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_192 · Cited by 24
Abnormal error processing in depressive states: a translational examination in humans and rats
Beard, C., Donahue, R. J., Dillon, D. G., Veer, A. V., Webber, C. J., Lee, J., Barrick, E. M., Hsu, K. J., Foti, D., Carroll, F. I., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.54 · Cited by 24
“20,21 CRF administration is known to induce depression-and anxiety-like phenotypes in rodents, 22,23 and we have previously found that CRF infusion degrades 5CSRTT performance, yielding decreases in correct responding, increased omission errors, increased latencies to respond correctly and…”
BackgroundPoretti, M. B., Sawant, R. S., Rask‐Andersen, M., de Cúneo, M. F., Schiöth, H. B., Pérez, M. F., & Carlini, V. P. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4187-4 · Cited by 24
Deng, X., Fu, J., Yang, S. T., Xu, B., Ji, Z., Guo, Q., & Ma, S. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.001 · Cited by 22
“HPA axis dysfunctions in depression were manifested as aberrant adrenal glucocorticoid (GC) secretion and abnormal hormone feedback loops (Nemeroff et al., 1984; Bardeleben and Wiedemann, 1987).”
Chapter 1 Recent Advances in Corticotropin-Releasing Factor Receptor Antagonists
Dzierba, C. D., Hartz, R. A., & Bronson, J. J. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00001-8 · Cited by 22
Corticotropin-Releasing Factor
Valentino, R. J., & Bockstaele, E. V. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50064-0 · Cited by 23
The CRH stimulation test in bereaved subjects with and without accompanying depression
Roy, A., Gallucci, W. T., Avgerinos, P. C., Linnoila, M., & Gold, P. W. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90045-5 · Cited by 22
Krishnan, K. R. R., Rayasam, K., Reed, D., Smith, M., Chapell, P., Saunders, W. B., Ritchie, J. C., Carroll, B. J., & Nemeroff, C. B. (1993) · Depression · doi:10.1002/depr.3050010303 · Cited by 23
Self-citationBaseline studies on transmitter substances in cerebrospinal fluid in depression
Gjerris, A. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb10571.x · Cited by 22
Stimulation of the pituitary-adrenal axis with arginine vasopressin in patients with depression
Meller, W. H., Kathol, R. C., Jaeckle, R. S., & López, J. F. (1987) · Journal of Psychiatric Research · doi:10.1016/0022-3956(87)90028-8 · Cited by 22
Magnetic resonance in patients with affective illness
McDonald, W. M., & Krishnan, K. R. R. (1992) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02195977 · Cited by 24
Adrenocorticotropin hormone, β-endorphin and cortisol responses to oCRF in melancholic patients
Maes, M. H. J., Claes, M., Vandewoude, M. F. J., Schotte, C., Martín, M. J. J., Blockx, P. P., & Cosyns, P. (1992) · Psychological Medicine · doi:10.1017/s0033291700030269 · Cited by 22
Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities
Caruso, A., Gaetano, A., & Scaccianoce, S. (2022) · Biology · doi:10.3390/biology11121785 · Cited by 24
“Although there is currently no consensus on a suitable biological biomarker(s) underpinnings depression [55], it has been reported that the cerebrospinal fluid of depressed patients contains elevated levels of CRH [56].”
BackgroundEffects of neurosteroids on the human corticotropin-releasing hormone gene
Budziszewska, B., Zając, A., Basta‐Kaim, A., Leśkiewicz, M., Steczkowska, M., Lasoń, W., & Kaciński, M. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70365-0 · Cited by 21
Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls
Roy, A. (1991) · Neuropharmacology · doi:10.1016/s0028-3908(11)80014-6 · Cited by 21
Bondy, B., & Zill, P. (2008) · Nucleic acids and molecular biology · doi:10.1007/978-3-540-85383-1_7 · Cited by 23
“CRH and arginin-vasopressin (ACV) are the main activators of the HPA system and an increase of these neuropeptides was shown in brains from depressed suicide victims (Arato et al. 1989; Nemeroff et al. 1984; Raadsheer et al. 1994).”
BackgroundA follow up study of suicide attempters: Increase of CSF–somatostatin but no change in CSF–CRH
Westrin, Å., Ekman, R., Regnéll, G., & Träskman‐Bendz, L. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00073-6 · Cited by 21
Depression in Late Life: An Update
Blazer, D. G. (1990) · Springer eBooks · doi:10.1007/978-3-662-40455-3_6 · Cited by 21
The influence of corticosterone on serotonergic stereotypy and sexual behavior in the female rat
Hanson, L., & Gorzalka, B. B. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00046-7 · Cited by 21
Leake, A., & Ferrier, I. N. (1993) · Drugs & Aging · doi:10.2165/00002512-199303050-00003 · Cited by 23
Stress-responsive neuromodulators
Gold, P. W. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90172-2 · Cited by 22
Linthorst, A. C. E., & Reul, J. M. H. M. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_9 · Cited by 21
Forman, S. D., Bissette, G., Yao, J., Nemeroff, C. B., & van Kammen, D. P. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90083-3 · Cited by 23
Self-citationStokes, P. E., Maas, J. W., Davis, J. M., Koslow, S. H., Casper, R. C., & Stoll, P. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.7.868 · Cited by 22
Fast-Acting Antidepressants: Can the Need be Met?
Norman, T. R., & Leonard, B. E. (1994) · CNS Drugs · doi:10.2165/00023210-199402020-00005 · Cited by 22
Cortical and subcortical neuropeptides in Alzheimer's disease
Auchus, A. P., Green, R. C., & Nemeroff, C. B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90102-3 · Cited by 23
Self-citationSomatostatin regulation of the CRF-ACTH-cortisol axis
Serby, M., Richardson, S. B., Bart Rypma, A., Twente, S., & Rotrosen, J. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90273-8 · Cited by 21
Kiani, A. K., Maltese, P. E., Dautaj, A., Paolacci, S., Kurti, D., Picotti, P. M., & Bertelli, M. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i13-s.10536 · Cited by 24
“In 1984, Nemeroff and co-workers found elevated concentrations of corticotropin-releasing factor in cerebrospinal fluid of MDD patients, leading to the suggestion that elevated activity of this factor in the central nervous system could explain hypothalamic-pituitaryadrenal hyperactivity in MDD (20), leading in turn t…”
BackgroundA Polymorphism in the Crhr1 Gene Determines Stress Vulnerability in Male Mice
Labermaier, C., Kohl, C., Hartmann, J., Devigny, C., Altmann, A., Weber, P. C., Arloth, J., Quast, C., Wagner, K. V., Scharf, S. H., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1986 · Cited by 21
Waldherr, M., Nyuyki, K. D., Maloumby, R., Bosch, O. J., & Neumann, I. D. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.11.006 · Cited by 23
Effects of sertraline on regional neuropeptide concentrations in olfactory bulbectomized rats
Bissette, G. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00513-5 · Cited by 25
Self-citationPost, A., Ohl, F., Almeida, O. F. X., Binder, E. B., Rücker, M., Welt, S., Binder, E., Holsboer, F., & Sillaber, I. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2134-x · Cited by 22
“Given the key role assigned to the HPA axis in the regulation of emotion and mood (Nemeroff et al. 1984; Holsboer 1999; Nestler et al. 2002) as well as the known direct actions of CRH on these behaviors (Holsboer 2000; Pariante and Miller 2001; Nemeroff and Owens 2002; Nestler et al.”
BackgroundPOST-MORTEM STUDIES OF NEUROTRANSMITTER BIOCHEMISTRY IN DEPRESSION AND SUICIDE
Cheetham, S. C., Katona, C., & Horton, R. W. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-356510-5.50012-1 · Cited by 20
Psychological Distress and Disease Course for Women With Breast Cancer: One Answer, Many Questions
Spiegel, D. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.10.629 · Cited by 20
Functional expression of brain cholecystokinin and bombesin receptors in Xenopus oocytes
Moriarty, T. M., Gillo, B., Sealfon, S. C., Roberts, J. L., Blitzer, R. D., & Landau, E. M. (1988) · Molecular Brain Research · doi:10.1016/0169-328x(88)90021-6 · Cited by 20
Morley, J. E., & Kaiser, F. E. (1992) · Drugs & Aging · doi:10.2165/00002512-199202040-00006 · Cited by 20
Kim, H., Lim, T., Ha, G. E., Lee, J., Kim, J., Chang, N., Kim, S. H., Kim, K. H., Lee, J., Cho, Y., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01082-1 · Cited by 19
“In some patients with depression, hypothalamic PVN displays increased CRF concentrations in the cerebrospinal fl uid 7 , increased CRF immunoreactivity 8 , and CRF mRNA overexpression 9 .”
The pathophysiology and management of depression in cardiac surgery patients
Vu, T., & Smith, J. A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1195028 · Cited by 23
Brain mechanisms of stress and depression in coronary artery disease
Bremner, J. D., Campanella, C., Khan, Z., Fani, N., Kasher, N., Evans, S., Reiff, C. M., Mishra, S., Ladd, S. L., Nye, J. A., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.11.017 · Cited by 23
“, 2000), and patients with major depression show alterations in stress responsive neurohormonal systems, including cortisol and norepinephrine (Bremner, J.D. et al., 2003a; Carroll, 1982; Carroll et al., 1976; Charney et al., 1982; Delgado and Moreno, 2000; Lake et al., 1982; Nemeroff et al., 1984; Ordway et al., 1994…”
BackgroundBiomarker-Guided Tailored Therapy
Lydiard, J. B., & Nemeroff, C. B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_10 · Cited by 19
Self-citationExploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
Omori, N. E., Malys, M. K., Woo, G. H., & Mansor, L. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1142682 · Cited by 21
High Plasma Concentrations of Cortisol and Thromboxane B2 in Patients With Depression
Piccirillo, G., Fimognari, F. L., Infantino, V., Monteleone, G., Fimognari, G. B., Falletti, D., & Marigliano, V. (1994) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199403000-00011 · Cited by 19
Neonatal Isolation Enhances Anxiety-like Behavior Following Early-life Seizure in Rats
Lai, M., Yang, S., & Huang, L. (2008) · Pediatrics & Neonatology · doi:10.1016/s1875-9572(08)60006-6 · Cited by 21
Maes, M. H. J., Minner, B., Suy, E., D'Hondt, P., Jacobs, M.-P., & Raus, J. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90016-m · Cited by 19
Psychoneuroendocrine characteristics of common obesity clinical subtypes
Martins, J. M., Trinca, A., Afonso, A., Carreiras, F., Falcão, J., Nunes, J., do Vale, S., & da Costa, J. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801500 · Cited by 19
Tian, X., Hsin, L., WEBSTER, E. L., Contoreggi, C. S., Chrousos, G. P., Gold, P. W., Habib, K. E., Ayala, A. R., Eckelman, W. C., Jacobson, A. E., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00661-2 · Cited by 19
Krohg, K., Hageman, I., & Balslev Jørgensen, M. (2008) · Nordic Journal of Psychiatry · doi:10.1080/08039480801983588 · Cited by 18
“Depressive patients, not yet pharmacologically treated, show elevated concentrations of CRF in the CSF (32), elevated CRF concentrations in PVN (33) and down-regulation of CRFR1 in the frontal cortex (34).”
BackgroundImmunological Interfaces: The COVID-19 Pandemic and Depression
Perlmutter, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.657004 · Cited by 18
Poggini, S., Bon, G. M., Golia, M. T., Albanese, N. C., Viglione, A., Poleggi, A., Limatola, C., Maggi, L., & Branchi, I. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113256 · Cited by 21
Bouzinova, E. V., Wiborg, O., Aalkjær, C., & Matchkov, V. V. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000187 · Cited by 19
“This is in accordance with clinical studies showing increased noradrenaline concentration and elevated components of the hypothalamic–pituitary– adrenal axis (eg, cortisol and adrenocorticotropic hormone) in response to stressors and orthostatic challenges, suggesting a hyperactive stress response in association with…”
ResultKim, S. H., Han, J. E., Hwang, S., & Oh, D. H. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.11.1646 · Cited by 18
“Previous human studies have also found elevated levels of CRF in the cerebrospinal fluid of patients with depression (2, 3) or posttraumatic stress disorder (PTSD) (4-6).”
BackgroundTakahashi, Y., Hashizume, M., Shin, K., Terauchi, T., Takeda, K., Hibi, S., Murata-Tai, K., Fujisawa, M., Shikata, K., Taguchi, R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300864p · Cited by 20
Corticosteroids Mediate Heart Failure-Induced Depression through Reduced σ1-Receptor Expression
Shinoda, Y., Tagashira, H., Bhuiyan, M. S., Hasegawa, H., Kanai, H., Zhang, C., Han, F., & Fukunaga, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163992 · Cited by 19
Ohmura, Y., Yamaguchi, T., Izumi, T., Matsumoto, M., & Yoshioka, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.023 · Cited by 19
Chang, J. P.-C., Chen, Y.-T., & Su, K. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/725310 · Cited by 20
Heuser, I. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_8 · Cited by 18
The Role of Corticotropin-Releasing Factor in the Pathophysiology of Psychiatric Disorders
Musselman, D. L., & Nemeroff, C. B. (1993) · Psychiatric Annals · doi:10.3928/0048-5713-19931201-07 · Cited by 18
Self-citationBehavioural physiology of serotonergic and steroid-like anxiolytics as antistress drugs
Bohus, B., Koolhaas, J. M., Korte, S. M., Korte-Bouws, G. A. H., Eisenga, W., & Smit, J. (1990) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80079-x · Cited by 18
Huang, T., Huang, S. ‐., & Hsu, M. M. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03349671 · Cited by 18
The Hypothalamic-Pituitary-Adrenocortical Axis an Major Depression
Stokes, P. E., & Sikes, C. R. (1988) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30881-8 · Cited by 20
Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides
Charlton, B. G., Cheetham, S. C., Horton, R. W., Katona, C., Crompton, M. R., & Ferrier, I. N. (1988) · Journal of Psychopharmacology · doi:10.1177/026988118800200103 · Cited by 20
CORTICOTROPHIN RELEASING FACTOR IN MAN AND ITS MEASUREMENT: A REVIEW
Linton, E. A., & Lowry, P. J. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01246.x · Cited by 19
“In support of this hypothesis was the demonstration of increased levels of CRF in the cerebrospinal fluid (CSF) of depressed patients (Nemeroff et al., 1984; Banki et al., 1987; Widerlov et al., 1988).”
BackgroundSasaki‐Hamada, S., Yuri, Y., Hoshi, M., & Oka, J.-I. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.010 · Cited by 17
Heinzmann, J.-M., Kloiber, S. M., Mattos, G. E., Bielohuby, M., Palme, R., Holsboer, F., Uhr, M., Ising, M., Touma, C., & McIlwrick, S. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.542 · Cited by 17
Dogra, S., Sona, C., Kumar, A., & Yadav, P. N. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.03.012 · Cited by 19
Neurodevelopmental liabilities in schizophrenia and affective disorders
Palomo, T., Kostrzewa, R. M., Archer, T., & Beninger, R. J. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000022061 · Cited by 20
“Rats subjected to daily periods of maternal separation shortly after birth, showed similarly elevated ACTH and corticosterone responses to stress as adults, and chronically elevated CSF levels of CRH as well as elevated expression of CRH mRNA in the paraventricular nucleus (PVN) of the hypothalamus (Plotsky and Meany,…”
BackgroundInfluentialBremner, J. D., Cheema, F. A., Ashraf, A., Afzal, N., Fani, N., Reed, L., Musselman, D. L., Ritchie, J., Faber, T. L., Votaw, J. R., et al. (2009) · Stress and Health · doi:10.1002/smi.1246 · Cited by 18
“The concentration of stress hormones, including cortisol and noradrenaline, has been reported to be increased in patients with depression (Carroll, 1982; Nemeroff et al., 1984; Traskman et al., 1980; Young, Haskett, & Grunhaus, 1994).”
BackgroundSelf-citationSaavedra, J. M., & Pavel, J. (2005) · Drug Development Research · doi:10.1002/ddr.20027 · Cited by 18
Rogóż, Z. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70180-x · Cited by 18
Wróbel, A., Serefko, A., Woźniak, A., Kociszewski, J., Szopa, A., Wiśniewski, R., & Poleszak, E. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172842 · Cited by 17
“Disturbances in the CRF system are observed in depressed patients [31-33] and they play a significant role in urinary bladder overactivity [34].”
Augustyn, M., Otczyk, M., Budziszewska, B., Jagła, G., Nowak, W., Basta‐Kaim, A., Jaworska-Feil, L., Kubera, M., Tetich, M., Leśkiewicz, M., et al. (2005) · PubMed · Cited by 17
Cerebrospinal fluid neuropeptides in dementia
Bánki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90132-j · Cited by 17
Self-citationSuemaru, S., Suemaru, K., Kawai, K., Miyata, S., Nobukuni, K., Ihara, Y., Namba, R., Urakami, K., & Hashimoto, K. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02215-5 · Cited by 17
Hartz, R. A., Gilligan, P. J., Nanda, K. K., Tebben, A. J., Fitzgerald, L. W., & Miller, K. J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00741-7 · Cited by 17
Takamori, K., Kawashima, N., Chaki, S., Nakazato, A., & Kameo, K. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00515-9 · Cited by 17
Emerging treatments for major depression
Norman, T. R., & Burrows, G. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.2.203 · Cited by 17
Waselus, M., & Bockstaele, E. J. V. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.014 · Cited by 21
“For instance, elevated CRF levels in cerebrospinal fluid (CSF) have been reported in a number of depressed patients [48].”
BackgroundLesch, K., Widerlöv, E., Ekman, R., Laux, G., Schulte, H. M., Pfüller, H., & Beckmann, H. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90271-5 · Cited by 18
“Compared with controls, depressed patients exhibited a significantly blunted ACTH response and a normal co&o1 secretion after CRH, in association with elevated basal cortisol concentrations; this probably indicates a (XI-I-induced HPA system hyperactivity and at least partial integrity of the glucocorticoid-dependent…”
BackgroundSelf-citationKumagai, T., Okubo, T., Kataoka-Okubo, H., Chaki, S., Okuyama, S., & Nakazato, A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00005-0 · Cited by 17
Michelson, D., Altemus, M., Galliven, E., Hill, L., Greenberg, B. D., & Gold, P. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00210-5 · Cited by 17
Neuentwicklungen in der Pharmakotherapie der Depression
Rupprecht, R., Baghai, T. C., & Möller, H. ‐. (2003) · Der Nervenarzt · doi:10.1007/s00115-003-1517-2 · Cited by 19
Maes, M. H. J., D'Hondt, P., Martín, M. J. J., Claes, M., Schotte, C., Vandewoude, M. F. J., & Blockx, P. P. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05544.x · Cited by 17
Bjartell, A. S., Ekman, R., Bergquist, S., & Widerlöv, E. (1989) · Psychoneuroendocrinology · doi:10.1016/0306-4530(89)90004-8 · Cited by 17
Self-citationChakraborty, S., Tripathi, S. J., Raju, T. R., & Rao, B. S. S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110000 · Cited by 16
Skuza, G., Szymańska, M., Budziszewska, B., Abate, C., & Berardi, F. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70722-8 · Cited by 16
Discovering the Potentials of Medicinal Mushrooms in Combating Depression – A Review
Lew, S. Y., Teoh, S. L., Lim, S., Lim, L. W., & Wong, K.-H. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200526125534 · Cited by 17
In search of sex-related mediators of affective illness
Sikes-Keilp, C., & Rubinow, D. R. (2021) · Biology of Sex Differences · doi:10.1186/s13293-021-00400-4 · Cited by 17
Suicide: Allostatic regulation and resilience
Stacy, M. A., & Schulkin, J. A. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105691 · Cited by 18
Heim, C., Newport, D. J., Bonsall, R., Miller, A. H., & Nemeroff, C. B. (2003) · Focus · doi:10.1176/foc.1.3.282 · Cited by 15
Self-citationHypothalamic stress systems in mood disorders
(2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-819973-2.00003-4 · Cited by 15
(2000) · doi:10.1002/1520-6394(2000)12:1+<2::aid-da2>3.0.co;2-4
Self-citation
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.